Emergence, spread, and environmental effect of antimicrobial resistance: How use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else

被引:214
作者
O'Brien, TF
机构
[1] Brigham & Womens Hosp, Dept Med, Microbiol Lab, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, WHO, Collaborating Ctr Surveillance Antimicrobial Resi, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1086/340244
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Use of an antimicrobial agent selects for overgrowth of a bacterial strain that has a gene expressing resistance to the agent. It also selects for the assembly and evolution of complex genetic vectors encoding, expressing, linking, and spreading that and other resistance genes. Once evolved, a competitive construct of such genetic elements may spread widely through the world's bacterial populations. A bacterial isolate at any place may thus be resistant-not only because nearby use of antimicrobials had amplified such a genetic construct locally, but also because distant use had caused the construct or its components to evolve in the first place and spread there. The levels of resistance at any time and place may therefore reflect in part the total number of bacteria in the world exposed to antimicrobials up until then. Tracing the evolution and spread of such genetic elements through bacterial populations far from one another, such as those of animals and humans, can be facilitated by newer genetic methods.
引用
收藏
页码:S78 / S84
页数:7
相关论文
共 40 条
[1]   Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella:: Implications for the use of fluoroquinolones in food animals [J].
Angulo, FJ ;
Johnson, KR ;
Tauxe, RV ;
Cohen, ML .
MICROBIAL DRUG RESISTANCE, 2000, 6 (01) :77-83
[2]   PERIODIC SELECTION IN ESCHERICHIA-COLI [J].
ATWOOD, KC ;
SCHNEIDER, LK ;
RYAN, FJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1951, 37 (03) :146-155
[3]  
Baquero F, 1997, CIBA F SYMP, V207, P93
[4]  
Courvalin Patrice, 1996, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V190, P467
[5]   Heterogeneity in the vanB gene cluster of genomically diverse clinical strains of vancomycin-resistant enterococci [J].
Dahl, KH ;
Simonsen, GS ;
Olsvik, O ;
Sundsfjord, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1105-1110
[6]  
Davies JE, 1997, CIBA F SYMP, V207, P15
[7]   Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. [J].
Donskey, CJ ;
Chowdhry, TK ;
Hecker, MT ;
Hoyen, CK ;
Hanrahan, JA ;
Hujer, AM ;
Hutton-Thomas, RA ;
Whalen, CC ;
Bonomo, RA ;
Rice, LB .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1925-1932
[8]  
Dowson Christopher G., 1994, Trends in Microbiology, V2, P361, DOI 10.1016/0966-842X(94)90612-2
[9]   Evolution of structure and substrate specificity in D-alanine:D-alanine ligases and related enzymes [J].
Evers, S ;
Casadewall, B ;
Charles, M ;
DutkaMalen, S ;
Galimand, M ;
Courvalin, P .
JOURNAL OF MOLECULAR EVOLUTION, 1996, 42 (06) :706-712
[10]   Emergence and dissemination of quinolone-resistant Escherichia coli in the community [J].
Garau, J ;
Xercavins, M ;
Rodríguez-Carballeira, M ;
Gómez-Vera, JR ;
Coll, I ;
Vidal, D ;
Llovet, T ;
Ruíz-Bremón, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2736-2741